Oleamide

Oleamide

SCHEMBL9983275

CCCCCCCCC=CCCCCCCCC(N)=O.N

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 4/20 0.96
▸ SOAT1 P35610 2/20 0.96
▸ CYP1A2 P05177 2/20 0.96
▸ CYP2C19 P33261 2/20 0.96
▸ KMT2A Q03164 2/20 0.96
▸ MEN1 O00255 1/20 0.96
▸ TP53 P04637 1/20 0.96
▸ CYP3A4 P08684 1/20 0.96
▸ KDM4E B2RXH2 2/20 0.85
▸ CNR1 P21554 1/20 0.75
▸ TERT O14746 3/20 0.68
▸ PTPN1 P18031 3/20 0.68
▸ PPARG P37231 3/20 0.68
▸ PPARD Q03181 3/20 0.68
▸ PPARA Q07869 3/20 0.68
▸ MAPT P10636 2/20 0.68
▸ BLM P54132 2/20 0.68
▸ HSD17B10 Q99714 2/20 0.68
▸ FABP4 P15090 2/20 0.68
▸ GMNN O75496 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleamide SCHEMBL30525722 1.00 FAAH (0.96) FAAHSOAT1CYP1A2CYP2C19KMT2A
Ammonia Solution, Strong SCHEMBL8466380 1.00 FAAH (0.96) FAAHSOAT1CYP1A2CYP2C19KMT2A
Oleamide SCHEMBL27961302 0.98 FAAH (0.92) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL446991 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21501560 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL23528231 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21983255 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21654359 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL22419041 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL10445392 0.98 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023173242-A1 α-FAPBI3 PEROVSKITE QUANTUM DOT AND PREPARATION METHOD THEREFOR, AND PHOTOELECTRIC DEVICE 中国科学院深圳先进技术研究院 2023-09-21 — — WO claimed
CN-114644919-B α-FAPbI 3 Perovskite quantum dot, preparation method and photoelectric device 中国科学院深圳先进技术研究院 2023-02-24 — — CN claimed
CN-114644919-A α-FAPbI3Perovskite quantum dot, preparation method and photoelectric device 中国科学院深圳先进技术研究院 2022-06-21 — — CN claimed
WO-2024103421-A1 YB3+-DOPED CSPBBR3 PMSCS, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳先进技术研究院 2024-05-23 — — WO disclosed
WO-2024103422-A1 MN2+ AND YB3+ DOUBLE-DOPED CSPBBR3PMSCS, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国科学院深圳先进技术研究院 2024-05-23 — — WO disclosed
US-11981876-B2 Wax inhibitors with improved flowability CLARIANT INTERNATIONAL LTD (CH) 2024-05-14 — — US disclosed
CN-115746843-B Mn 2+ And Yb 3+ Double-doped CsPbBr 3 PMSCs, preparation method and application thereof 中国科学院深圳先进技术研究院 2024-02-09 — — CN disclosed
CN-115710502-B Yb 3+ Doped CsPbBr 3 PMSCs, preparation method and application thereof 深圳先进技术研究院 2024-01-02 — — CN disclosed
WO-2023173242-A1 α-FAPBI3 PEROVSKITE QUANTUM DOT AND PREPARATION METHOD THEREFOR, AND PHOTOELECTRIC DEVICE 中国科学院深圳先进技术研究院 2023-09-21 — — WO disclosed
EP-4004142-B1 WAX INHIBITORS WITH IMPROVED FLOWABILITY CLARIANT INT LTD (CH) 2023-06-07 — — EP disclosed
CN-115746843-A Mn 2+ And Yb 3+ Double-doped CsPbBr 3 PMSCs and preparation method and application thereof 中国科学院深圳先进技术研究院 2023-03-07 — — CN disclosed
US-9249377-B2 Cleaning formula for motor vehicle intake and exhaust systems BG INTELLECTUAL, INC. (US) 2016-02-02 — — US disclosed
US-20140331954-A1 CLEANING FORMULA FOR MOTOR VEHICLE INTAKE AND EXHAUST SYSTEMS BG INTELLECTUALS, INC. (US) 2014-11-13 — — US disclosed
US-20140314852-A1 NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2014-10-23 — — US disclosed
EP-2792350-A1 NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS Universidade De Santiago De Compostela (ES) 2014-10-22 — — EP disclosed
CN-103801114-A Purification assistant for coal chemical industry production and application thereof in coal chemical industry production ZHANG ZHENGBEI 2014-05-21 — — CN disclosed
US-8211205-B1 Method of controlled synthesis of nanoparticles UT DOTS, INC. (US) 2012-07-03 — — US disclosed
CN-1325620-C Lubricating oil composition comprising an additive combination of a carboxylic acid and an amine as ant-rust agent SHELL INT RESEARCH (NL) 2007-07-11 — — CN disclosed
CN-1522295-A Lubricating oil composition comprising an additive combination of a carboxylic acid and an amine as ant-rust agent ���ʿ����о����޹�˾ 2004-08-18 — — CN disclosed
CN-1162604-A Polymer, preparation processes thereof, hair-treating compositions and cosmetic compositions MITSUI TOATSU CHEMICALS (JP) 1997-10-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140314852-A1 NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS MLEC, LAGE3, SORBS1 FAAH 4209/4885SOAT1 1605/4885CYP1A2 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback